Furthermore, the number of both macrophages, CD11bhigh and CD11blow F4/80+ sMΦs, in salivary glands of anti-CCL22-treated mice was significantly decreased compared with that of control IgG-treated SS model mice (Figure 5C), suggesting that other cells would be activated by secreting CCL22. Here, CCL22 is linked to synovial sarcoma.